Morgan Stanley Maintains Equal-Weight Rating for Steris: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Morgan Stanley has maintained its Equal-Weight rating for Steris (NYSE:STE) and increased its price target from $206.00 to $225.00. Steris shares are currently trading down 0.96% at $225.62 per share. Steris is a medical device company focused on sterilization services and infection prevention, with 70% of its revenue derived from U.S. operations.
August 04, 2023 | 1:56 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley maintains its Equal-Weight rating for Steris and raises its price target. Steris shares are currently trading down 0.96% at $225.62.
The news of Morgan Stanley maintaining its Equal-Weight rating for Steris and raising its price target is directly relevant to Steris. However, the impact on the stock price is neutral in the short term as the shares are currently trading down 0.96% at $225.62, which is close to the new price target.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100